Study of 2 million patients maps benefits and risks of new weight-loss drugs

GLP-1 medications associated with lower risks of Alzheimer's and heart disease, but higher risks of pancreatitis and kidney problems.

Study of 2 million patients maps benefits and risks of new weight-loss drugs.

Study of 2 million patients maps benefits and risks of new weight-loss drugs.

(photo credit: MKPhoto12. Via Shutterstock)

ByJERUSALEM POST STAFF

JANUARY 23, 2025 12:35

RECOMMENDED STORIES

Palestinian Hamas terrorists keep guard on the day Hamas handed over deceased hostages in Khan Younis in the southern Gaza Strip February 20, 2025.

Admitting defeat? Why Hamas officials say the terror group 'lost control' of Gaza

JULY 7, 2025

Members of Hamas with the backdrop of the Gaza Strip, amid reports that Hamas has lost control of much of its territory.

'Security situation has collapsed': Hamas has lost 80% of its control over Gaza Strip

JULY 7, 2025

Sheikh Wadee' al-Jaabari.

Reporter's Notebook: 'Post' meets with top Hebron sheikh who wants to pull out of PA

JULY 6, 2025

IDF Maj.-Gen. Aviad Dagan entering a fighter jet; illustrative.

IDF cyber chief, retired Iran strategy head piloted fighter jets striking Iran

JULY 6, 2025

Hot Opinion

War doesn't end on the battlefield: Israel must better support veterans with PTSD

ByJPOST EDITORIAL

Zvika Klein

Israel's midnight strategist: How IDF chief Eyal Zamir rewired the doctrine on Iran

ByZVIKA KLEIN, YONAH JEREMY BOB

As thousands stay away, Ethiopian Israelis pay a heavy price in Gaza war

Can Donald Trump win a Nobel Peace Prize?